Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seongho Kim

Showing results (241-250 of 251) with videos related to

Pageof 26
Sort By:
Clinical and Translational Medicine|December 22, 2023
Molecular analysis of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in KPC pancreatic cancer mouse modelMd Hafiz Uddin, Mohammad Najeeb Al-Hallak, Husain Yar Khan, et al.
Gynecologic Oncology|September 12, 2024
Cervical squamous cell carcinoma outcomes across continents: A retrospective studyDeepti Jain, Fadi Zaeim, Marya Wahidi, et al.
Advanced Materials (Deerfield Beach, Fla.)|June 3, 2026
Designable van der Waals Crystal for Artificial Neuronal Cell MimickingJinhyoung Lee, Gunhyoung Kim, Dongho Lee, et al.
Cancer Letters|September 25, 2024
RCC1 regulation of subcellular protein localization via Ran GTPase drives pancreatic ductal adenocarcinoma growthSahar F Bannoura, Amro Aboukameel, Husain Yar Khan, et al.
Medrxiv : the Preprint Server for Health Sciences|June 17, 2024
Single nucleus transcriptomics, pharmacokinetics, and pharmacodynamics of combined CDK4/6 and mTOR inhibition in a phase 0/1 trial of recurrent high-grade gliomaKevin C Johnson, An-Chi Tien, Jun Jiang, et al.
Neuro-Oncology|November 9, 2025
Single nucleus transcriptomics, pharmacokinetics, and pharmacodynamics of CDK4/6 and mTOR inhibition in a phase 0/1 trial of recurrent high-grade gliomaKevin C Johnson, An-Chi Tien, Jun Jiang, et al.
Vaccines|April 23, 2022
COVID-19 Vaccine Hesitancy among Arab AmericansMira H Kheil, Deepti Jain, Jamil Jomaa, et al.
Molecular Cancer Therapeutics|July 11, 2019
Novel Pyrrolo[3,2-<i>d</i>]pyrimidine Compounds Target Mitochondrial and Cytosolic One-carbon Metabolism with Broad-spectrum Antitumor EfficacyAamod S Dekhne, Khushbu Shah, Gregory S Ducker, et al.
Molecular Cancer Therapeutics|January 5, 2023
Correction: Novel Pyrrolo[3,2-d]Pyrimidine Compounds Target Mitochondrial and Cytosolic One-Carbon Metabolism with Broad-spectrum Antitumor EfficacyAamod S Dekhne, Khushbu Shah, Gregory S Ducker, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 30, 2022
Outcomes Among Classical Hodgkin Lymphoma Patients After an Interim PET Scan: A Real-World ExperienceMuhammad Saad Hamid, Sarah C Rutherford, Hyejeong Jang, et al.
Pageof 26

Showing results (241-250 of 251) with videos related to

Sort By:
Pageof 26
Clinical and Translational Medicine|December 22, 2023
Molecular analysis of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in KPC pancreatic cancer mouse modelMd Hafiz Uddin, Mohammad Najeeb Al-Hallak, Husain Yar Khan, et al.
Gynecologic Oncology|September 12, 2024
Cervical squamous cell carcinoma outcomes across continents: A retrospective studyDeepti Jain, Fadi Zaeim, Marya Wahidi, et al.
Advanced Materials (Deerfield Beach, Fla.)|June 3, 2026
Designable van der Waals Crystal for Artificial Neuronal Cell MimickingJinhyoung Lee, Gunhyoung Kim, Dongho Lee, et al.
Cancer Letters|September 25, 2024
RCC1 regulation of subcellular protein localization via Ran GTPase drives pancreatic ductal adenocarcinoma growthSahar F Bannoura, Amro Aboukameel, Husain Yar Khan, et al.
Medrxiv : the Preprint Server for Health Sciences|June 17, 2024
Single nucleus transcriptomics, pharmacokinetics, and pharmacodynamics of combined CDK4/6 and mTOR inhibition in a phase 0/1 trial of recurrent high-grade gliomaKevin C Johnson, An-Chi Tien, Jun Jiang, et al.
Neuro-Oncology|November 9, 2025
Single nucleus transcriptomics, pharmacokinetics, and pharmacodynamics of CDK4/6 and mTOR inhibition in a phase 0/1 trial of recurrent high-grade gliomaKevin C Johnson, An-Chi Tien, Jun Jiang, et al.
Vaccines|April 23, 2022
COVID-19 Vaccine Hesitancy among Arab AmericansMira H Kheil, Deepti Jain, Jamil Jomaa, et al.
Molecular Cancer Therapeutics|July 11, 2019
Novel Pyrrolo[3,2-<i>d</i>]pyrimidine Compounds Target Mitochondrial and Cytosolic One-carbon Metabolism with Broad-spectrum Antitumor EfficacyAamod S Dekhne, Khushbu Shah, Gregory S Ducker, et al.
Molecular Cancer Therapeutics|January 5, 2023
Correction: Novel Pyrrolo[3,2-d]Pyrimidine Compounds Target Mitochondrial and Cytosolic One-Carbon Metabolism with Broad-spectrum Antitumor EfficacyAamod S Dekhne, Khushbu Shah, Gregory S Ducker, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 30, 2022
Outcomes Among Classical Hodgkin Lymphoma Patients After an Interim PET Scan: A Real-World ExperienceMuhammad Saad Hamid, Sarah C Rutherford, Hyejeong Jang, et al.
Pageof 26